Condensed Statements of Cash Flows - USD ($)	1 Months Ended	3 Months Ended			7 Months Ended	9 Months Ended	10 Months Ended
	Mar. 31, 2021	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Cash Flows From Operating Activities:
Net income	$ (13,153)	$ 505,538	$ 7,622,890	$ 3,374,061	$ 3,351,666	$ 9,487,675
Adjustments to reconcile net income to net cash used in operating activities:
Investment income earned on treasury securities held in the Trust Account		(762,820)		(1,665)	(1,665)	(1,006,251)
Costs associated with warrant liabilities					735,630	0
Gain on change in fair value of derivative liabilities		(68,218)		(10,138,000)	(10,138,000)	(11,344,950)
Share-based compensation					5,761,500	0
Changes in operating assets and liabilities:
Prepaid expenses					(404,384)	272,039
Accounts payable and accrued expenses					91,309	1,121,222
Net Cash Used In Operating Activities					(603,944)	(1,470,265)
Cash Flows From Investing Activities:
Cash deposited into the Trust Account					(169,000,000)	0
Net Cash Used In Investing Activities					(169,000,000)	0
Cash Flows From Financing Activities:
Sale of Units in the Initial Public Offering, net of underwriting discount					165,620,000	0
Sale of Private Placement Warrants to the Sponsor					6,380,000	0
Proceeds from related party advances					0	1,594
Repayment of the related party advances					0	(27,250)
Payment of offering costs					(660,108)	0
Net Cash (Used In) From Financing Activities					171,339,892	(25,656)
Net change in cash						(1,495,921)
Cash at beginning of year	$ 0		1,569,803		0	1,569,803	$ 0
Cash at end of year		73,882		$ 1,735,948	1,735,948	73,882	$ 1,569,803
Supplemental disclosure of non-cash financing activities:
Deferred offering costs paid by Sponsor in exchange for Class B ordinary shares					25,000	0
Deferred offering costs paid by Sponsor					20,600	0
Supplemental disclosure of non-cash financing activities:
Measurement adjustment of carrying value to redemption value		$ 762,820	$ 22,183		0	1,013,217
Deferred underwriting compensation charged to additional paid-in capital in connection with the Initial Public Offering					$ 5,915,000	$ 0